Search Medical Condition
Please enter condition
Please choose location from dropdown

Windmere, New York Clinical Trials

A listing of Windmere, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (695) clinical trials

The study will evaluate the safety and effectiveness of the Ranger™ drug-coated balloon to open and prevent the re-narrowing of your blood vessel. Paclitaxel is a commonly used drug in other commercially approved devices. The addition of the Paclitaxel drug coating on the balloon could improve the performance of a ...

Phase

8.9 miles

Learn More »

This study will observe the continued performance of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in a real-world more-comer population.

Phase N/A

8.9 miles

Learn More »

To evaluate whether long-term treatment with bempedoic acid 180 mg/day versus placebo reduces the risk of major adverse cardiovascular events (MACE) in patients with, or at high risk for, cardiovascular disease (CVD) who are statin intolerant. This will be assessed with a composite primary efficacy endpoint that includes time to ...

Phase

8.9 miles

Learn More »

The purpose of this study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease. The treatment options this study will compare are Hybrid Coronary Revascularization (HCR), a combination of surgery and catheter procedures to open clogged heart arteries, and Percutaneous Coronary Intervention (PCI), ...

Phase N/A

8.9 miles

Learn More »

The objective of this event-driven trial is to demonstrate superiority of empagliflozin 10 mg versus placebo in patients with symptomatic, chronic HF and preserved ejection fraction (LVEF > 40%) under stable treatment of HF symptoms.

Phase

8.9 miles

Learn More »

The primary objective of this study is to establish the safety and effectiveness of the WATCHMAN Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for anti-coagulation therapy to reduce the risk of stroke. The ...

Phase N/A

8.9 miles

Learn More »

The purpose of this study is to assess the Medtronic Intrepid TMVR system in patients with severe Mirtral regurgitation, a transcatheter mitral valve replacment.

Phase N/A

8.9 miles

Learn More »

To evaluate the use of a resynchronization defibrillator (or CRT-D) versus a CRT-D and ablation to treat permanent AF.

Phase N/A

8.9 miles

Learn More »

The purpose of the PSR platform is to provide continuing evaluation and periodic reporting ofsafety and effectiveness of market-released products for their intended use. PSR data will support post-market surveillance activities initiated by Medtronic and post-approval studies directed by a government and/or a regulatory authority. Conducting product surveillance in large ...

Phase N/A

8.9 miles

Learn More »

The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the absence of antihypertensive medications.

Phase N/A

8.9 miles

Learn More »